Literature DB >> 1975253

Effect of dietary vitamin E on the development of altered hepatic foci and hepatic tumors induced by the peroxisome proliferator ciprofibrate.

H P Glauert1, M M Beaty, T D Clark, W S Greenwell, V Tatum, L C Chen, T Borges, T L Clark, S R Srinivasan, C K Chow.   

Abstract

The purpose of this study was to determine the effect of the dietary antioxidant vitamin E on hepatocarcinogenesis by peroxisome proliferators which, it is hypothesized, induce tumors by increased production of hydrogen peroxide or other oxygen radicals. Rats were fed diets containing the peroxisome proliferator ciprofibrate and one of three concentrations (10, 50, or 500 ppm) of alpha-tocopheryl acetate for 6 months or 21 months. The incidence of hepatic tumors and the number and volume of gamma-glutamyl-transpeptidase-positive, ATPase-negative, glucose-6-phosphatase-negative, and glucose-6-phosphatase-positive foci were quantified. No tumors or altered hepatic foci were seen at 6 months, but at 21 months the incidence of hepatic tumors and the number and volume of altered hepatic foci were increased in rats fed higher levels of vitamin E. Indices of oxidative damage--concentrations of malonaldehyde, conjugated dienes, and lipid-soluble fluorescence products--were not affected or were lower in rats fed higher amounts of vitamin E; the enhancing effect of vitamin E on the development of altered hepatic foci and hepatic tumors, therefore, was not related to the induction of cellular oxidative damage. Hepatic peroxisomal fatty acid beta-oxidation and vitamin C concentrations were not affected by vitamin E, whereas the glutathione concentration was decreased in rats fed higher amounts of vitamin E. This study shows that increasing the vitamin E content of the diet enhances ciprofibrate-induced hepatocarcinogenesis, but the mechanism of this effect is unclear.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1975253     DOI: 10.1007/bf01612917

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  28 in total

1.  Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids.

Authors:  S T Omaye; J D Turnbull; H E Sauberlich
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

2.  Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent.

Authors:  J Sedlak; R H Lindsay
Journal:  Anal Biochem       Date:  1968-10-24       Impact factor: 3.365

3.  Histochemical and ultrastructural demonstration of gamma-glutamyl transpeptidase activity.

Authors:  A M Rutenburg; H Kim; J W Fischbein; J S Hanker; H L Wasserkrug; A M Seligman
Journal:  J Histochem Cytochem       Date:  1969-08       Impact factor: 2.479

Review 4.  The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney.

Authors:  J M Hawkins; W E Jones; F W Bonner; G G Gibson
Journal:  Drug Metab Rev       Date:  1987       Impact factor: 4.518

5.  Application of quantitative stereology to the evaluation of phenotypically heterogeneous enzyme-altered foci in the rat liver.

Authors:  H A Campbell; Y D Xu; M H Hanigan; H C Pitot
Journal:  J Natl Cancer Inst       Date:  1986-04       Impact factor: 13.506

6.  Assay of peroxisomal beta-oxidation of fatty acids.

Authors:  P B Lazarow
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

7.  Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments.

Authors:  R Peto; M C Pike; N E Day; R G Gray; P N Lee; S Parish; J Peto; S Richards; J Wahrendorf
Journal:  IARC Monogr Eval Carcinog Risk Chem Hum Suppl       Date:  1980

8.  A high-performance liquid chromatographic method for the determination of tocopherol in plasma and cellular elements of the blood.

Authors:  L J Hatam; H J Kayden
Journal:  J Lipid Res       Date:  1979-07       Impact factor: 5.922

9.  Development of hepatic lesions in male Fischer-344 rats fed AIN-76A purified diet.

Authors:  M A Medinsky; J A Popp; T E Hamm; J G Dent
Journal:  Toxicol Appl Pharmacol       Date:  1982-01       Impact factor: 4.219

10.  Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in the semipurified diet.

Authors:  N D Lalwani; M K Reddy; S A Qureshi; J K Reddy
Journal:  Carcinogenesis       Date:  1981       Impact factor: 4.944

View more
  3 in total

1.  Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid.

Authors:  M W Wilson; L T Lay; C K Chow; H H Tai; L W Robertson; H P Glauert
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

2.  Role of the p50 subunit of NF-kappaB in vitamin E-induced changes in mice treated with the peroxisome proliferator, ciprofibrate.

Authors:  Karen G Calfee-Mason; Eun Y Lee; Brett T Spear; Howard P Glauert
Journal:  Food Chem Toxicol       Date:  2008-02-05       Impact factor: 6.023

Review 3.  The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions.

Authors:  J Christopher Corton; Jeffrey M Peters; James E Klaunig
Journal:  Arch Toxicol       Date:  2017-12-02       Impact factor: 5.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.